Navigation Links
ViroPharma to Present at Three Upcoming Healthcare Conferences
Date:9/3/2007

EXTON, Pa., Aug. 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, vice-president, chief operating officer and chief financial officer of ViroPharma, will present at the Thomas Weisel Partners 2007 Healthcare Conference at 8:00 A.M. ET on Wednesday, September 5, 2007. The conference is being held at the Four Seasons Hotel in Boston, MA.

Mr. Milano will also present at the 14th Annual BioCentury Newsmakers in the Biotech Industry Conference at 1:30 P.M. ET on Thursday, September 6, 2007. The conference is being held at the Millennium Broadway Hotel in New York.

ViroPharma also announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the Bear Stearns 20th Annual Healthcare Conference at 3:30 P.M. ET on Monday, September 10, 2007. The conference is being held at the Grand Hyatt in New York.

ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conference.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of The European Association for the Study of the Liver
2. The Past, Present and Future of HLA Typing
3. Sygnis Pharma AG announces date for presentation of clinical results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The global spinal implants and surgical ... CAGR of 5.3% from 2016 to 2021. Factors such as the presence ... spending on healthcare, and rising income levels are propelling the growth of ...
(Date:12/5/2016)... -- Research and Markets has announced the addition of ... Share, Development, Growth and Demand Forecast to 2022" report to ... , , ... pregnancy rapid test market is expected to grow at a CAGR ... test market is witnessing high growth, due to growing female geriatric ...
(Date:12/5/2016)... SAN ANTONIO , Dec. 5, 2016  Seno ... opto-acoustic technology as a new tool to improve the ... will present data from its European MAESTRO post-market surveillance ... Antonio Breast Cancer Symposium (SABCS) taking place from ... Center in San Antonio, Texas . ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... ... Will Never Be The Same” is a fictional tale about growing up with the ... the creation of published author, Kim T. Briggs, a self-described “big kid” who has ... and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama skits ...
(Date:12/5/2016)... Lakes, NJ (PRWEB) , ... December 05, 2016 ... ... recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” Gibson ... Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus , ...
(Date:12/5/2016)... ... December 05, 2016 , ... The legislation – ... direct supervision of a licensed physical therapist, to render care for certain patients. ... treatment plan from a licensed physical therapist (PT) and throughout the treatment cycle ...
(Date:12/5/2016)... ... ... MBA has joined the Retina Group of New York (RGONY) specializing in uveitis ... MD and has been providing tertiary medical and surgical retinal care on Long Island for ... her peers. Growing up in a family of doctors, Dr. Shah emulated the role ...
(Date:12/5/2016)... ... ... The new knee compression sleeves come as a pair which will provide instantly ... and any sport that requires knee compression or protection from the demands of ... quality knee sleeve performance. Firstly it is made out of premium 7mm thick neoprene ...
Breaking Medicine News(10 mins):